Cytomel (Liothyronine) Sleep Architecture Impact: What T3 Does to Your Sleep

What the Cytomel label says about sleep

Insomnia appears twice in the Cytomel prescribing information: in the central nervous system list of adverse reactions, with headache, hyperactivity, nervousness, anxiety, irritability and emotional lability, and again among the most common adverse reactions [1]. The label states that these reactions are primarily those of hyperthyroidism due to therapeutic overdosage, a category that also includes palpitations, tachycardia, arrhythmias, heat intolerance, excessive sweating and weight loss [1].

Do trials show T3 changing sleep?

Trials of levothyroxine plus liothyronine are the closest human data. A 2006 meta-analysis in the Journal of Clinical Endocrinology and Metabolism pooled 11 randomized trials with 1,216 adults and found no difference between combination therapy and levothyroxine alone for bodily pain, depression, anxiety, fatigue, quality of life, body weight or lipids; adverse events did not differ [3]. A 2025 systematic review in the same journal found a similar adverse-event risk for combination therapy versus monotherapy in randomized trials (relative risk 1.22, 95% CI 0.66 to 2.25, n=2,128). In an observational cohort analysis of 630,254 people, the relative risk of atrial fibrillation with liothyronine versus levothyroxine alone was 1.10 (95% CI 0.74 to 1.63) [4].

A 1999 randomized crossover trial studied 33 adults with hypothyroidism, each treated for two five-week periods. In one period 50 mcg of the usual levothyroxine dose was replaced by 12.5 mcg of liothyronine. Six of 17 cognitive and mood scores were better or closer to normal on the combination, and 10 of 15 mood and physical-status scales were significantly better, with a slightly higher pulse rate [5].

What timing data exist?

The label instructs once-daily oral dosing, individualized by response and laboratory findings, and describes a rapid onset of action with maximum pharmacologic response within 2 or 3 days [1]. It attaches no time of day to the once-daily instruction [1].

A 2015 phase I study gave a single 50 mcg dose to 12 healthy euthyroid volunteers: T3 concentrations peaked at 2.5 hours, heart rate rose by 5 hours and the rise was transient, and TSH suppression began at 2 hours, reached its lowest point at 12 hours and lasted 2 to 3 days [2].